Search - tctmd.com

Displaying 141 - 160 of 390

Sort: Relevancy | Date

Presentation TCT 2016

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Presenter: Stephen G. Ellis, Patrick W. Serruys, Holger M. Nef

November 01, 2016

Presentation TCT 2016

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel

November 01, 2016

Presentation TCT 2016

A Critical Review of Technique Across the Absorb Trials

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

Presenter: Stephen G. Ellis, Patrick W. Serruys, David G. Rizik

November 01, 2016

Presentation TCT 2016

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Christoph K. Naber

November 01, 2016

Presentation TCT 2016

BRS Benchtop Findings: Implications for Implantation Techniques

Presenter: Stephen G. Ellis, Patrick W. Serruys, Nicolas Foin

November 01, 2016

Presentation TCT 2016

Impact of Different PLLA Polymers and BRS Construction on Implant Technique: From Absorb to DESolve to Fantom to Manli and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

BRS Snapshots: ArterioSorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

Case #1: A Novel Issue With a Bioresorbable Scaffold

Presenter: Antonio Colombo, Jeffrey W. Moses, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

EXCEL Outcomes in Men and Women

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Presenter: Stephen G. Ellis, Corrado Tamburino, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

Presenter: Thomas F. Luscher, Patrick W. Serruys, D. Christopher Metzger

October 31, 2016

Presentation TCT 2016

FORWARD: Multicenter, Prospective Registry Evaluating a Repositionable Self-Expanding Aortic Bioprosthesis in Patients with Severe Aortic Stenosis

Presenter: Thomas F. Luscher, Patrick W. Serruys, Stephan Windecker

October 31, 2016

Presentation TCT 2016

A Prospective, Randomized Trial of Impella vs Intra-aortic Balloon Counterpulsation in Patients with Cardiogenic Shock

Presenter: Thomas F. Luscher, Patrick W. Serruys, Jose P.S. Henriques

October 31, 2016

Presentation TCT 2016

GRACIA-4 (and Pooled Analysis): A Prospective, Randomized Trial of Percutaneous Coronary Intervention in Patients with STEMI with and without Preceding Fibrinolytic Therapy

Presenter: Thomas F. Luscher, Patrick W. Serruys, Francisco Fdez-Aviles

October 31, 2016

Presentation TCT 2016

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Presenter: Thomas F. Luscher, Patrick W. Serruys, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu

October 31, 2016

Presentation TCT 2016

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo

October 31, 2016

Advertisement

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

A Critical Review of Technique Across the Absorb Trials

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided?

BRS Benchtop Findings: Implications for Implantation Techniques

Impact of Different PLLA Polymers and BRS Construction on Implant Technique: From Absorb to DESolve to Fantom to Manli and More

BRS Snapshots: ArterioSorb

MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS

Case #1: A Novel Issue With a Bioresorbable Scaffold

EXCEL Outcomes in Men and Women

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

FORWARD: Multicenter, Prospective Registry Evaluating a Repositionable Self-Expanding Aortic Bioprosthesis in Patients with Severe Aortic Stenosis

A Prospective, Randomized Trial of Impella vs Intra-aortic Balloon Counterpulsation in Patients with Cardiogenic Shock

GRACIA-4 (and Pooled Analysis): A Prospective, Randomized Trial of Percutaneous Coronary Intervention in Patients with STEMI with and without Preceding Fibrinolytic Therapy

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content